The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors

被引：0
|
作者：
George T. Grossberg
Facundo Manes
Ricardo F. Allegri
Luis Miguel Gutiérrez-Robledo
Sergio Gloger
Lei Xie
X. Daniel Jia
Vojislav Pejović
Michael L. Miller
James L. Perhach
Stephen M. Graham
机构：
[1] Saint Louis University School of Medicine,Department of Neurology and Psychiatry
[2] Instituto de Neurología Cognitiva (INECO),undefined
[3] Instituto de Investigaciones Neurológicas Raúl Carrea (FLENI),undefined
[4] Instituto de Geriatría,undefined
[5] Institutos Nacionales de Salud de México,undefined
[6] PsicoMedica Clinical and Research Group,undefined
[7] Forest Research Institute,undefined
[8] Prescott Medical Communications Group,undefined
来源：
CNS Drugs | 2013年 / 27卷
关键词：
Memantine; Cholinesterase Inhibitor; Semantic Fluency; Verbal Fluency Test; Severe Impairment Battery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：469 / 478
页数：9
相关论文
共 31 条
  • [1] A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease
    Herrmann, Nathan
    Gauthier, Serge
    Boneva, Neli
    Lemming, Ole Michael
    INTERNATIONAL PSYCHOGERIATRICS, 2013, 25 (06) : 919 - 927
  • [2] Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan
    Nakamura, Yu
    Kitamura, Shin
    Homma, Akira
    Shiosakai, Kazuhito
    Matsui, Daiju
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (07) : 913 - 925
  • [3] Safety and tolerability of once-daily versus twice-daily memantine: a randomised, double-blind study in moderate to severe Alzheimer's disease
    Jones, Roy W.
    Bayer, Antony
    Inglis, Fraser
    Barker, Andrew
    Phul, Ravinder
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2007, 22 (03) : 258 - 262
  • [4] Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: A randomized, double-blind, placebo-controlled trial
    Porsteinsson, Anton P.
    Grossberg, George T.
    Mintzer, Jacobo
    Olin, Jason T.
    CURRENT ALZHEIMER RESEARCH, 2008, 5 (01) : 83 - 89
  • [5] Memantine treatment for Japanese patients with moderate to severe Alzheimer's disease: a meta-analysis of double-blind, randomized, placebo-controlled trials
    Kishi, Taro
    Matsunaga, Shinji
    Iwata, Nakao
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2018, 14 : 2915 - 2922
  • [6] A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease
    Farlow, Martin R.
    Thompson, Richard E.
    Wei, Lee-Jen
    Tuchman, Alan J.
    Grenier, Elaine
    Crockford, David
    Wilke, Susanne
    Benison, Jeffrey
    Alkon, Daniel L.
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 67 (02) : 555 - 570
  • [7] Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer's disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial
    Koh, Seong-Ho
    Kwon, Hyuk Sung
    Choi, Seong Hye
    Jeong, Jee Hyang
    Na, Hae Ri
    Lee, Chan Nyoung
    Yang, YoungSoon
    Lee, Ae Young
    Lee, Jae-Hong
    Park, Kyung Won
    Han, Hyun Jeong
    Kim, Byeong C.
    Park, Jin Se
    Lee, Jee-Young
    Kim, Sangjae
    Lee, Kyu-Yong
    ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)
  • [8] Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: randomized, double-blind, placebo-controlled study
    Amidfar, M.
    Khiabany, M.
    Kohi, A.
    Salardini, E.
    Arbabi, M.
    Azizi, M. Roohi
    Zarrindast, M. -R.
    Mohammadinejad, P.
    Zeinoddini, A.
    Akhondzadeh, S.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2017, 42 (01) : 44 - 50
  • [9] Efficacy and tolerability of adjunctive gabapentin and memantine in obsessive compulsive disorder: Double-blind, randomized, placebo-controlled trial
    Farnia, Vahid
    Gharehbaghi, Haniyeh
    Alikhani, Mostafa
    Almasi, Afshin
    Golshani, Sanobar
    Tatari, Faeze
    Davarinejad, Omran
    Salemi, Safora
    Bahmani, Dena Sadeghi
    Holsboer-Trachsler, Edith
    Brand, Serge
    JOURNAL OF PSYCHIATRIC RESEARCH, 2018, 104 : 137 - 143
  • [10] Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial
    Farokhnia, Mehdi
    Sabet, Mehdi Shafiee
    Iranpour, Negar
    Gougol, Amirhossein
    Yekehtaz, Habibeh
    Alimardani, Roozbeh
    Farsad, Farzaneh
    Kamalipour, Maryam
    Akhondzadeh, Shahin
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2014, 29 (04) : 351 - 359
1234